What is the reason why doctors are not prescribing Belvique or other diet pills. There are so many obese people in the world and they are not using diet pills, what is wrong with these people?
SPPI did not release the results on SPI-2012, in my opinion is that no matter how successful the clinical results are on their drugs, the stock price hardly moves up while other bio-pharmaceuticals whenever
they announce a positive results on phase I or II, their stock price moves up as if there was an FDA approval.
SPPI is scorned by the wall street people and shorted by traders all the time.
Me as an investor of SPPI have been frustrated for so long and could put the blame on the management
for the underperformance of this company. They have so many drugs in the market yet it is always
reporting loses while other companies without any drugs in the market keep on flourishing with high stock prices.
I still think Raj is the main reason this company is not heading upward in price. He should give up his seat
along with his lieutenants. SPPI is still posting loses despite the 5 drugs in the market. They are putting too much money in their pocket.
Sell the company now before it loses all its cash that it raised when it sold shares before the FDA approval of Belviq.
$16 to $17 is a low estimate. They have too many drugs in the market + more in clinical trials.
There are many small pharma that are worth more without any drugs in the market. Raj is the only
sticking point why this company is not moving any higher. SPPI should be around $30 with
good execution in marketing SPPI's products.
Time to sell the company to the Chinese. They have a lot of people with cancer in China due to their pollution
and industrialization. Maybe a Chinese company will offer $5
My bet is that they will be getting some funding from those ice bucket viral dare/donations for the ALS
I share the same sentiments. NAVB should be sold out to relieve the retail investors of prolonged agony.
This company does not have an leg to stand up. Its has been underperforming since lymphoseek was approved.
Just hope that Adam F. is in the slammer that he can not write any more. His article on GALT was the main reason GALT was down to $4.
Sentiment: Strong Buy
This the shorties strategy of bringing down small cap pharma so they don't have to cover much. They try entice others to go along that drives the price down further and then they cover.
FDA approval of Firdapse will be welcomed. Small cap bio-pharmas have been dragged to the ground since February with relentless negative articles from SA, The Street, especially from Adam F. It's about time
small cap bio-pharmas get some positive news.
I hope they press the board to sell the company. Selling the company is the only last resort to get back
to its previous highs and the only way that small investors can recoup their loses.
You're a total moron. Let's see whose got the last laugh when FDA approves ACADs
drug by years end.
Waiting for some good news on the clinical trials to get some bump.
Sentiment: Strong Buy
There is a need to fire the entire management and the BOD for mismanaging this company. SPPI has been underperforming for the last 3 years. A change in the top management is welcomed.
There are a lot of small cap pharma that have lost 40 to 60% of their value since February and CTIC is just
one of them. There are a lot of us that are frustrated with this situation where all indexes are breaking the records highs except small pharma.